Legal status · Australia
Is KLOW blend legal in Australia?
No. KLOW blend is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
KLOW blend in Australia at a glance
| Classification | Not approved; Schedule 4 or import-restricted |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the KLOW blend profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing KLOW blend is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What KLOW blend is
A four-peptide vendor blend, typically 50 mg GHK-Cu with 10 mg each of KPV, BPC-157 and TB-500, sold for repair and inflammation; no study has ever tested the combination, and GHK-Cu makes up most of the vial.
KLOW is one of the most widely stocked gray-market products of 2026. It bundles the copper peptide GHK-Cu (about 62% of the vial by mass) with the anti-inflammatory tripeptide KPV and the healing peptides BPC-157 and TB-500.
Mechanism: Assumed sum of the parts: copper-peptide collagen and repair signaling (GHK-Cu), MC1R and NF-kB anti-inflammatory effects (KPV), and BPC-157/TB-500 tissue-repair pathways, all from animal or in-vitro work.
Regulatory history: Not approved; unstudied combination
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for KLOW blend at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
KLOW blend in other countries
United States
Not approvedNot approved; sold 'for research use only'
Is KLOW blend legal in the United States?United Kingdom
Not approvedUnlicensed medicine; supply for human use is unlawful
Is KLOW blend legal in the United Kingdom?Canada
Not approvedNot authorized for sale
Is KLOW blend legal in Canada?Frequently asked questions
Is KLOW blend legal in Australia?
No. KLOW blend is not an approved medicine in Australia; its classification is "Not approved; Schedule 4 or import-restricted". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy KLOW blend in Australia?
No approved product exists to buy. In Australia KLOW blend is classified as "Not approved; Schedule 4 or import-restricted", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is KLOW blend TGA approved?
No. In Australia KLOW blend is classified as "Not approved; Schedule 4 or import-restricted", which is not a TGA marketing approval. For comparison, the US FDA status is: Not approved; unstudied combination. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for KLOW blend live on its compound profile.
KLOW blend profileThis page is general information about the regulatory status of KLOW blend in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.